Integral Ad Science (NASDAQ:IAS) PT Lowered to $12.00

Integral Ad Science (NASDAQ:IAS) had its price objective lowered by Barclays from $16.00 to $12.00 in a research report released on Monday morning, Benzinga reports. The brokerage currently has an equal weight rating on the stock.

A number of other research analysts have also weighed in on the company. BMO Capital Markets cut their price objective on Integral Ad Science from $18.00 to $16.00 and set an outperform rating on the stock in a report on Wednesday, February 28th. Raymond James lowered Integral Ad Science from a strong-buy rating to an outperform rating and dropped their target price for the stock from $20.00 to $16.00 in a report on Wednesday, February 28th. Oppenheimer dropped their target price on Integral Ad Science from $25.00 to $20.00 and set an outperform rating on the stock in a report on Wednesday, February 28th. Bank of America assumed coverage on Integral Ad Science in a report on Thursday, January 11th. They set a buy rating and a $19.00 target price on the stock. Finally, Truist Financial dropped their target price on Integral Ad Science from $26.00 to $17.00 and set a buy rating on the stock in a report on Wednesday, February 28th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, Integral Ad Science has an average rating of Moderate Buy and an average price target of $17.96.

Integral Ad Science Stock Down 3.3 %

Shares of IAS stock opened at $9.54 on Monday. The stock’s 50-day simple moving average is $11.82 and its 200-day simple moving average is $13.11. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.21 and a current ratio of 3.21. The firm has a market capitalization of $1.52 billion, a PE ratio of 238.56, a P/E/G ratio of 1.71 and a beta of 1.60. Integral Ad Science has a fifty-two week low of $9.10 and a fifty-two week high of $20.88.

Integral Ad Science (NASDAQ:IAS) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The business had revenue of $134.30 million for the quarter, compared to analyst estimates of $131.27 million. Integral Ad Science had a return on equity of 0.83% and a net margin of 1.53%. The company’s revenue was up 14.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.07 earnings per share. Equities analysts expect that Integral Ad Science will post 0.16 earnings per share for the current year.

Insider Activity

In other news, CEO Lisa Utzschneider sold 13,113 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $15.79, for a total value of $207,054.27. Following the transaction, the chief executive officer now owns 148,657 shares in the company, valued at $2,347,294.03. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $10.24, for a total value of $32,532.48. Following the transaction, the chief accounting officer now owns 120,195 shares in the company, valued at $1,230,796.80. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Lisa Utzschneider sold 13,113 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $15.79, for a total value of $207,054.27. Following the completion of the transaction, the chief executive officer now owns 148,657 shares in the company, valued at approximately $2,347,294.03. The disclosure for this sale can be found here. Insiders have sold a total of 80,195 shares of company stock worth $876,562 over the last quarter. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Integral Ad Science

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Richelieu Gestion SA lifted its position in Integral Ad Science by 35.0% during the first quarter. Richelieu Gestion SA now owns 19,501 shares of the company’s stock worth $194,000 after buying an additional 5,055 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Integral Ad Science during the fourth quarter worth approximately $3,159,000. HBK Investments L P purchased a new position in Integral Ad Science during the fourth quarter worth approximately $4,317,000. Vanguard Group Inc. lifted its position in Integral Ad Science by 10.7% during the fourth quarter. Vanguard Group Inc. now owns 8,106,247 shares of the company’s stock worth $116,649,000 after buying an additional 780,469 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in Integral Ad Science by 605.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock worth $39,429,000 after buying an additional 2,351,414 shares in the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.